EUCTR2008-002102-19-IE进行中（未招募）1 期
Study VEG108844, a Study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma - COMPARZ
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 927
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Section deemed no longer required and removed from the protocol by
- •amendment No 5 (please refer to Section 11 the Appendix 7 of the
- •protocol amendment No 5). Enrolment is complete and the study has
- •been reported. This study remains open to allow subjects currently on
- •treatment continued access to their treatment (as determined by the
- •investigator). No new subjects will be entered.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 532
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 395
排除标准
- •Section deemed no longer required and removed from the protocol by
- •amendment No 5 (please refer to Section 11 the Appendix 7 of the
- •protocol amendment No 5). Enrolment is complete and the study has
- •been reported. This study remains open to allow subjects currently on
- •treatment continued access to their treatment (as determined by the
- •investigator). No new subjects will be entered.
研究者
相似试验
进行中（未招募）
1 期
A clinical trial comparing the effectiveness of pazopanib versus sunitinib in treating people with advanced kidney cancer.ocally Advanced and/or Metastatic Renal Cell CarcinomaMedDRA version: 19.1Level: PTClassification code 10050513Term: Metastatic renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-002102-19-GBovartis Pharma Services AG927
进行中（未招募）
1 期
Study VEG108844, a Study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinomaocally Advanced and/or Metastatic Renal Cell CarcinomaMedDRA version: 9.1Level: LLTClassification code 10050513Term: Metastatic renal cell carcinomaEUCTR2008-002102-19-NLGlaxoSmithKline Research & Development Ltd876
进行中（未招募）
1 期
A clinical trial comparing the effectiveness of pazopanib versus sunitinib in treating people with advanced kidney cancer.EUCTR2008-002102-19-DEGlaxoSmithKline Research & Development Ltd927
进行中（未招募）
1 期
A clinical trial comparing the effectiveness of pazopanib versus sunitinib in treating people with advanced kidney cancer.EUCTR2008-002102-19-SEovartis Pharma Services AG927
已完成
3 期
A study of pazopanib versus sunitinib in the treatment of subjects with locally advanced and/or metastatic renal cell carcinomaocally Advanced and/or Metastatic Renal Cell CarcinomaLocally Advanced and/or Metastatic Renal Cell CarcinomaCancer - KidneyACTRN12609000392268GlaxoSmithKline876